Trials / Completed
CompletedNCT01060787
Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant
An Observational Bilateral Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant for at Least One Year
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 98 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 6 Years
- Healthy volunteers
- Not accepted
Summary
Investigate the impact of the Fluocinolone Acetonide (FA) intravitreal implants
Detailed description
Investigate the impact of the Fluocinolone Acetonide (FA) intravitreal implants on corneal endothelial cell density.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Fluocinolone Acetonide 0.59 mg | At a single visit bilateral endothelial microscopy will be performed to determine endothelial cell density. |
| PROCEDURE | Fluocinolone Acetonide 2.1 mg | At a single visit bilateral endothelial microscopy will be performed to determine endothelial cell density. |
Timeline
- Start date
- 2016-02-04
- Primary completion
- 2019-03-07
- Completion
- 2019-06-07
- First posted
- 2010-02-02
- Last updated
- 2019-06-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01060787. Inclusion in this directory is not an endorsement.